Nanoparticle-Based Drugs: A Potential Armamentarium of Effective Anti-Cancer Therapies - PubMed (original) (raw)
Review
Nanoparticle-Based Drugs: A Potential Armamentarium of Effective Anti-Cancer Therapies
Khurshid Ahmad et al. Curr Drug Metab. 2018.
Abstract
Background: Cancer is a foremost cause of mortality worldwide. Available treatments are non-specific and cannot cross biological barriers, which have restricted their usages. Furthermore, the side effects of existing treatments have promoted the exploration of nanotechnological approaches to achieve site-specific drug delivery. The diminutive sizes of nanoparticles, and hence, their large surface to volume ratios, means they are inherently more efficient at delivering drugs to specific tumor sites. This review highlights different approaches to cancer therapy, and the importance of nanoparticles in cancer therapy. Applications and limitations of different types of nanomedicines used for cancer imaging and treatment are discussed.
Methods: We undertook extensive literature search of bibliographic databases (e.g. PubMed, Google Scholar, Medline, Web of Science etc.) using different keywords and combination of keywords to retrieve the relevant information.
Results: This review provides overview of cancer and need for nanoparticle-based therapies for their treatment, and deliberates the different types of nanomaterials used as nanomedicines for cancer imaging and treatment in addition to their applications and limitations. Furthermore, applications of nanoparticles in modern cancer therapies and research strategies have been explored to overcome cancer.
Conclusion: Nanotechnology has provided a lot of novel therapeutics for the diagnosis and treatment of different cancers over the last 2-3 decades. However, there are few limitations of nanotechnological based anti-cancer therapies. Nanotechnology is enabling novel, specialized treatments for cancer; this will be a high-impact area of nanomedicine yielding more medical advancements with the next 10 years.
Keywords: Cancer; drug delivery; nanodevices; nanomedicines; nanoparticles; therapeutics..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E, Fernández-Medarde A. Pérez-Herrero E, et al. Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Review. - Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
Piktel E, Niemirowicz K, Wątek M, Wollny T, Deptuła P, Bucki R. Piktel E, et al. J Nanobiotechnology. 2016 May 26;14(1):39. doi: 10.1186/s12951-016-0193-x. J Nanobiotechnology. 2016. PMID: 27229857 Free PMC article. Review. - The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S, Bayda S, Hadla M, Caligiuri I, Corona G, Toffoli G, Rizzolio F. Palazzolo S, et al. Curr Med Chem. 2018;25(34):4224-4268. doi: 10.2174/0929867324666170830113755. Curr Med Chem. 2018. PMID: 28875844 Review. - Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy.
Verma R, Rao L, Nagpal D, Yadav M, Kumar V, Kumar V, Kumar H, Parashar J, Bansal N, Kumar M, Pandey P, Mittal V, Kaushik D. Verma R, et al. Recent Pat Nanotechnol. 2024;18(4):395-414. doi: 10.2174/1872210517666230613154847. Recent Pat Nanotechnol. 2024. PMID: 37537775 Review. - Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES, Sharker SM, Islam MT, Khan IN, Shaw S, Rahman MA, Uddin SJ, Shill MC, Rehman S, Das N, Ahmad S, Shilpi JA, Tripathi S, Mishra SK, Mubarak MS. Ali ES, et al. Semin Cancer Biol. 2021 Feb;69:52-68. doi: 10.1016/j.semcancer.2020.01.011. Epub 2020 Jan 31. Semin Cancer Biol. 2021. PMID: 32014609 Review.
Cited by
- Investigation of the Immune Modulatory Potential of Zinc Oxide Nanoparticles in Human Lymphocytes.
Moratin H, Ickrath P, Scherzad A, Meyer TJ, Naczenski S, Hagen R, Hackenberg S. Moratin H, et al. Nanomaterials (Basel). 2021 Mar 3;11(3):629. doi: 10.3390/nano11030629. Nanomaterials (Basel). 2021. PMID: 33802496 Free PMC article. - Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel.
Amer EI, Abou-El-Naga IF, Boulos LM, Ramadan HS, Younis SS. Amer EI, et al. Biomedica. 2022 Mar 1;42(1):67-84. doi: 10.7705/biomedica.5913. Biomedica. 2022. PMID: 35471171 Free PMC article. - Nanodelivery of Natural Antioxidants: An Anti-aging Perspective.
Vaiserman A, Koliada A, Zayachkivska A, Lushchak O. Vaiserman A, et al. Front Bioeng Biotechnol. 2020 Jan 10;7:447. doi: 10.3389/fbioe.2019.00447. eCollection 2019. Front Bioeng Biotechnol. 2020. PMID: 31998711 Free PMC article. Review. - Mechanistic Insights into the Antimicrobial Actions of Metallic Nanoparticles and Their Implications for Multidrug Resistance.
Shaikh S, Nazam N, Rizvi SMD, Ahmad K, Baig MH, Lee EJ, Choi I. Shaikh S, et al. Int J Mol Sci. 2019 May 18;20(10):2468. doi: 10.3390/ijms20102468. Int J Mol Sci. 2019. PMID: 31109079 Free PMC article. Review. - Hepatic Cellular Distribution of Silica Nanoparticles by Surface Energy Modification.
Lee AR, Nam K, Lee BJ, Lee SW, Baek SM, Bang JS, Choi SK, Park SJ, Kim TH, Jeong KS, Lee DY, Park JK. Lee AR, et al. Int J Mol Sci. 2019 Aug 5;20(15):3812. doi: 10.3390/ijms20153812. Int J Mol Sci. 2019. PMID: 31387201 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources